(Press-News.org) Amsterdam, June 1, 2023 – Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year. Currently the only potential treatment for this condition is liver transplantation, which is available to very few patients. A first-in-human randomized controlled clinical trial using DIALIVE, a novel liver dialysis device, demonstrated its potential as a disease-modifying therapy and resolved liver failure significantly faster and in a greater proportion of patients compared with controls. Treatment of ACLF patients resulted in significant improvements in all the main underlying pathophysiological mechanisms of ACLF. Results appear in the Journal of Hepatology, published by Elsevier.
“DIALIVE is a novel liver dialysis device invented at University College London (UCL) by Dr. Nathan Davies and me. It is based on an understanding of the mechanisms underlying ACLF, which are what we are correcting with this machine by exchanging dysfunctional albumin and removing damage- and pathogen-associated molecular patterns,” explained lead investigator Rajiv Jalan, PhD, UCL Institute for Liver & Digestive Health, based at the Royal Free Hospital, London, and European Foundation for the Study of Chronic Liver Failure (EF Clif), Barcelona. “Two previous preclinical trials showed that this device saved the lives of animals with liver failure. These data were used to apply for an EU grant (ALIVER) to conduct this clinical trial.”
In this multicenter, randomized clinical trial investigators evaluated 32 alcoholic cirrhosis patients with ACLF who were treated with either DIALIVE or standard of care for up to five days. End points were assessed at Day 10. The primary aim was to evaluate DIALIVE’s safety in acute ACLF patients, while secondary aims were to assess clinical effects, device performance and effect on pathophysiologically-relevant biomarkers. Safety was assessed in all patients. The secondary aims were assessed in a pre-specified subgroup of 30 patients who had at least three treatment sessions with DIALIVE.
The study, which involved multiple centers across Europe, was led by clinical investigator Banwari Agarwal, MBBS, MD, consultant in liver ICU at the Royal Free Hospital.
It confirmed that the DIALIVE system is safe. In addition, patients experienced significant improvements on all the main underlying pathophysiological mechanisms of ACLF. This included improvement in albumin function, reduction in products of cell death and endotoxin, restoration of endothelial function, and cell signaling. Although the study was not powered for efficacy, it showed that the proportion of patients in which ACLF was resolved was greater with DIALIVE, and the time to resolution of ACLF was significantly reduced. It did not, however, reduce mortality in this small study. Therefore, larger clinical trials are needed in future to confirm DIALIVE’s efficacy and establish its safety.
“This is the first treatment that has shown such a rapid clinical effect in patients with ACLF,” said co-lead investigator Steffen Mitzner, MD, PhD, Fraunhofer IZI and Department of Medicine II, Division of Gastroenterology and Endocrinology, Rostock University Medical Center, Rostock, Germany. “The patients that resolved ACLF remained free of ACLF for 28 days despite only being treated with the device for three days. The improvement in biomarkers underlying the pathophysiology of ACLF was sustained even five days after stopping therapy.”
“These data indicate that DIALIVE may be a disease-modifying therapy for ACLF patients and could impact the outcome of patients with ACLF, for which there is no available therapy except liver transplantation available to a very small minority of these patients,” concluded Dr. Jalan. “The potential impact is huge if these data can be confirmed in larger clinical trials.”
“The positive results from this trial are great news for ACLF patients, and we are now preparing for a larger clinical trial,” added Carrie Morgan, Vice President, Clinical Operations, Yaqrit Discovery Ltd, a UCL spin-off company located in London and producer of DIALIVE.
ACLF is characterized clinically by multiorgan failure and high risk of short-term mortality and pathophysiologically by the presence of systemic inflammation. ACLF is a major global problem with prevalence rates of 20% to 30% in hospitalized cirrhosis patients. The worldwide reported mortality rate according to the EASL-CLIF Consortium definition is between 30% to 50% at 28-days from presentation.
END
New liver dialysis device shows potential to resolve liver failure in patients with acute-on-chronic liver failure
A clinical trial using DIALIVE to treat patients with liver failure demonstrated significant improvements on all main underlying pathophysiological mechanisms of acute-on-chronic liver failure, according to a new report in the Journal of Hepatology
2023-06-01
ELSE PRESS RELEASES FROM THIS DATE:
Liver dialysis device proved safe and effective for treating severe liver failure
2023-06-01
The first successful in-patient trial of liver dialysis* has been completed by researchers from UCL, the Royal Free Hospital, UCL spin-out Yaqrit and their collaborators.
The DIALIVE device, invented by researchers at UCL’s Institute for Liver and Digestive Health, was found to be safe and was associated with substantial improvement in the severity of symptoms and organ function in a greater proportion of patients with acute-on-chronic liver failure (ACLF), when compared with patients receiving standard of care.
The next step will be a larger clinical trial, which if successful could see DIALIVE approved for clinical use within the next three years.
Worldwide, it is estimated that there ...
Xrays reveal ancient secrets about our prehistoric world this World Dinosaur Day
2023-06-01
Researchers are shedding light on our ancient prehistoric world using state-of-the art Xray technology. This World Dinosaur Day, scientists are sharing the bones which lay beneath the Harbury Icthyosau – providing clues to dinosaur anatomy, physiology and evolution.
The University's of Warwick’s Centre for Imaging, Metrology and Additive Technologies (CiMAT) group at WMG has employed its cutting-edge equipment to explore the anatomy and biology of the Harbury Icthyosaur, a large marine reptile which lived on the Earth hundreds of millions of years ...
Phototherapy device has potential to be a novel treatment for sleep complaints
2023-05-31
DARIEN, IL – Wearing a phototherapy device that emits near-infrared light is associated with potential therapeutic benefits for sleep and daytime functioning, according to a new study to be presented at the SLEEP 2023 annual meeting.
Results show that self-reported, sleep-related symptoms improved after three weeks of treatment. Participants in the active treatment group reported experiencing better sleep quality, feeling more refreshed and relaxed, and functioning better during the day.
“This novel phototherapy device — while ...
UC Irvine-led interdisciplinary team delves into a heated debate about humidity
2023-05-31
Irvine, Calif., May 31, 2023 – As climate change increases the severity, frequency and duration of heat waves around the world, researchers at the University of California, Irvine and other institutions are sounding an alarm about what they consider to be an added threat to human health: humidity.
Heat extremes increase the risk of illness and death, with the worst outcomes among people who are older, have chronic diseases, live in hot climates and are socioeconomically disadvantaged. In addition, humidity causes heat stress by making it harder for bodies to cool, but medical and public health experts still disagree about ...
Level of support for gender-neutral option on state IDs affected by political orientation, social context
2023-05-31
Key takeaways
As of June, 22 U.S. states and the District of Columbia will offer the opportunity for residents to select a gender-neutral marker on government-issued IDs.
UCLA sociologist Abigail Saguy found that LGBTQ+ and feminist activists support both the addition of a gender-neutral option and the removal of gender identifiers on IDs.
Conservative activists oppose both measures.
As of June, 22 states and the District of Columbia will allow residents to select a gender-neutral “X” marker, rather than “male” or “female,” on their driver’s licenses, ...
NIH scientists find treatment for rare genetic skin disorder
2023-05-31
Researchers at the National Institutes of Health and their colleagues have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment. Scientists discovered that people with the disorder have an overactive version of a protein called STAT4, which regulates inflammation and wound healing. The work also identified a drug that targets an important feedback loop controlled by the STAT4 protein and significantly improves symptoms in these patients. The results were ...
UC hosts aerospace conference on artificial intelligence
2023-05-31
Aerospace experts from across North America are coming to the University of Cincinnati this week for a conference on artificial intelligence.
UC is playing host to the annual North American Fuzzy Information Processing Society's conference at UC's new Digital Futures building. It's an international research conference that will bring aerospace experts to Cincinnati to share the latest on artificial intelligence relating to drones, aviation, space exploration and other applications.
One of the conference sponsors, Thales, a French-based international holding company that engages in the manufacture, ...
$5M gift establishes Arts and Sciences outreach professorship
2023-05-31
CORNELL UNIVERSITY MEDIA RELATIONS OFFICE
FOR RELEASE: May 31, 2023
Rebecca Valli
cell: 607-793-1025
rv234@cornell.edu
$5M gift establishes Arts and Sciences outreach professorship
ITHACA, N.Y. – Bolstering its commitment to broader engagement, the College of Arts and Sciences has established the Winokur Professorship for the Public Understanding of Science and Mathematics.
Distinguished mathematician, award-winning teacher and well-known science communicator Steven Strogatz has been appointed as the inaugural holder of the chair. ...
New app uses AI to enable anyone to make musical mashups
2023-05-31
Imagine if the Police’s “Every Little Thing She Does Is Magic” opened Michael Jackson’s “Beat It,” then Cardi B’s “Bodak Yellow” riff blended with Jackson. This mix isn’t an impossible fantasy, but a reality with Mixboard, a tablet application that lets users without musical or editing experience create the songs of their dreams.
The app comes out of the Georgia Institute of Technology’s Center for Music Technology, whose director, Professor Gil ...
When countries cut taxes for new ideas, capital investments rise
2023-05-31
AUSTIN, Texas — Corporate tax breaks for innovation lead to two kinds of economic growth: in capital investment and highly compensated jobs, according to a new study from a researcher at The University of Texas at Austin.
Because innovation is key to growth in high-tech economies, one strategy has been to give companies a tax break for it. As of 2022, 21 countries worldwide had reduced rates for income resulting from intellectual property (IP), such as patents, copyrights and trademarks. Prior research has shown that such policies, known as “innovation boxes,” ...
LAST 30 PRESS RELEASES:
Evolution of fast-growing fish-eating herring in the Baltic Sea
Cryptographic protocol enables secure data sharing in the floating wind energy sector
Can drinking coffee or tea help prevent head and neck cancer?
Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration
Scientists unlock secrets behind flowering of the king of fruits
Texas A&M researchers illuminate the mysteries of icy ocean worlds
Prosthetic material could help reduce infections from intravenous catheters
Can the heart heal itself? New study says it can
Microscopic discovery in cancer cells could have a big impact
Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer
Breakthrough new material brings affordable, sustainable future within grasp
How everyday activities inside your home can generate energy
Inequality weakens local governance and public satisfaction, study finds
Uncovering key molecular factors behind malaria’s deadliest strain
UC Davis researchers help decode the cause of aggressive breast cancer in women of color
Researchers discovered replication hubs for human norovirus
SNU researchers develop the world’s most sensitive flexible strain sensor
Tiny, wireless antennas use light to monitor cellular communication
Neutrality has played a pivotal, but under-examined, role in international relations, new research shows
Study reveals right whales live 130 years — or more
Researchers reveal how human eyelashes promote water drainage
Pollinators most vulnerable to rising global temperatures are flies, study shows
DFG to fund eight new research units
Modern AI systems have achieved Turing's vision, but not exactly how he hoped
Quantum walk computing unlocks new potential in quantum science and technology
Construction materials and household items are a part of a long-term carbon sink called the “technosphere”
First demonstration of quantum teleportation over busy Internet cables
Disparities and gaps in breast cancer screening for women ages 40 to 49
US tobacco 21 policies and potential mortality reductions by state
AI-driven approach reveals hidden hazards of chemical mixtures in rivers
[Press-News.org] New liver dialysis device shows potential to resolve liver failure in patients with acute-on-chronic liver failureA clinical trial using DIALIVE to treat patients with liver failure demonstrated significant improvements on all main underlying pathophysiological mechanisms of acute-on-chronic liver failure, according to a new report in the Journal of Hepatology